Fulcrum Therapeutics

1 Follower

About

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Bryan Stuart
President & CEO
Bryan Stuart
Collapse
Judith Dunn
President, Research & Development
Mel Hayes
Chief Commercial Officer
Curtis Oltmans
General Counsel
Mani Sundararajan
SVP, Technical Operations
Peter Thomson
VP, Finance & Accounting
Kim Hazen
SVP, Human Resources
Nicole T. Gallagher
Director of Administration
Naomi Aoki
SVP, Corporate Communications and Investor Relations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.